09.11.2023 • News

Arkema to Extend Thierry Le Hénaff’s Contract as Chairman and CEO

Arkema board of directors has unanimously expressed its confidence in the company’s chairman and CEO Thierry Le Hénaff to execute the strategy announced during Arkema’s capital markets day on Sep. 27 and proposed the renewal of his term of office for four years at the company’s next annual shareholders meeting in May 2024.

The proposal is subject to approval by the company’s shareholders, Arkema said, adding that the board highlighted the “successful transformation of Arkema into a specialty materials player” in its decision to propose the renewal of Le Hénaff’s term of office as Arkema’s chairman and CEO.

Thierry Le Hénaff, Chairman and CEO, Arkema. © Bruno Mazodier/Arkema
Thierry Le Hénaff, Chairman and CEO, Arkema. © Bruno Mazodier/Arkema

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

29 April 2026 | This webinar explores how chemical industry organizations can design a digital‑ and AI‑ready operating model focused on clarity, usability, and measurable value.

Top-Feature

most read